Nurix Therapeutics (NRIX) Q2 2026 Earnings Report

595 Followers

NRIX Q2 2026 EPS Results

Actual EPS-$0.81

Consensus EPS-$0.72

Beat/MissMissed by -$0.09

One Year Ago EPS-$0.52

Actual Revenue$9.04M

Expected Revenue$15.29M

Beat/MissMissed by -$6.25M

YoY Revenue Growth-79.47%

QuarterQ2 2026

Date07/09/2026

TimeAfter Close

Conference CallThursday, July 9, 2026

NRIX Upcoming Earnings

Nurix Therapeutics's next earnings date is estimated for February 17, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Feb 17, 2027	2026 (Q4)	- / -	-0.82	―
Jul 09, 2026	2026 (Q2)	-0.72 / -0.81	-0.52	-55.77% (-0.29)
Apr 08, 2026	2026 (Q1)	-0.76 / -0.79	-0.67	-17.91% (-0.12)
Jan 28, 2026	2025 (Q4)	-0.87 / -0.82	-0.75	-9.33% (-0.07)
Oct 09, 2025	2025 (Q3)	-0.82 / -1.03	-0.67	-53.73% (-0.36)
Jul 09, 2025	2025 (Q2)	-0.72 / -0.52	-0.71	26.76% (+0.19)
Apr 08, 2025	2025 (Q1)	-0.76 / -0.67	-0.76	11.84% (+0.09)
Jan 28, 2025	2024 (Q4)	-0.69 / -0.75	-0.77	2.60% (+0.02)
Oct 11, 2024	2024 (Q3)	-0.69 / -0.67	-0.68	1.47% (+0.01)
Jul 11, 2024	2024 (Q2)	-0.64 / -0.71	-0.45	-57.78% (-0.26)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed